ACC.23/WCC — Dr Enoch Akowuah (James Cook University Hospital, UK) joins us to share the findings of the UK Mini-Mitral trial (National Institute of Health Research).
This study is a multicentre, expertise-based randomised controlled trial that aimed to compare the safety and effectiveness of a minimally-invasive thoracotomy compared to conventional sternotomy in treating patients with degenerative mitral valve disease. After surgery, patient outcomes were followed up for one year, whilst estimates of clinical and health-economic outcomes will continue to be reported for up to five years.
The trial saw a 96% repair rate in both arms.
- What is the importance of the UK Mini Mitral?
- What were the main considerations regarding the design of this trial?
- What were the baseline characteristics of the patients?
- What data did you present at ACC.23?
- How should these findings impact clinical practice?
- What are the next steps?
For more content from ACC.23/WCC head to Late-Breaking Science Video Collection.
Recorded on-site at ACC.23/WCC, New Orleans.
Editor: Mirjam Boros
Video production: Oliver Miles, Dan Brent, Mike Knight